Inhibition of autophagy curtails visual loss in a model of autosomal dominant optic atrophy
- PMID: 32788597
- PMCID: PMC7423926
- DOI: 10.1038/s41467-020-17821-1
Inhibition of autophagy curtails visual loss in a model of autosomal dominant optic atrophy
Abstract
In autosomal dominant optic atrophy (ADOA), caused by mutations in the mitochondrial cristae biogenesis and fusion protein optic atrophy 1 (Opa1), retinal ganglion cell (RGC) dysfunction and visual loss occur by unknown mechanisms. Here, we show a role for autophagy in ADOA pathogenesis. In RGCs expressing mutated Opa1, active 5' AMP-activated protein kinase (AMPK) and its autophagy effector ULK1 accumulate at axonal hillocks. This AMPK activation triggers localized hillock autophagosome accumulation and mitophagy, ultimately resulting in reduced axonal mitochondrial content that is restored by genetic inhibition of AMPK and autophagy. In C. elegans, deletion of AMPK or of key autophagy and mitophagy genes normalizes the axonal mitochondrial content that is reduced upon mitochondrial dysfunction. In conditional, RGC specific Opa1-deficient mice, depletion of the essential autophagy gene Atg7 normalizes the excess autophagy and corrects the visual defects caused by Opa1 ablation. Thus, our data identify AMPK and autophagy as targetable components of ADOA pathogenesis.
Conflict of interest statement
V.C. and A.A.S. are investigators in clinical trials with Leber’s hereditary optic neuropathy (LHON) sponsored by Edison Pharmaceuticals, GenSight Pharmaceuticals, and Stealth BioTherapeutics; V.C. is an investigator in a clinical trial with LHON sponsored by Santhera Pharmaceuticals, and both V.C. and A.A.S. have been consultants for Santhera; A.A.S. is consultant for Stealth BioTherapeutics. The remaining authors declare no competing interests.
Figures
References
-
- Hales KG, Fuller MT. Developmentally regulated mitochondrial fusion mediated by a conserved, novel, predicted GTPase. Cell. 1997;90:121–129. - PubMed
-
- Meeusen S, et al. Mitochondrial inner-membrane fusion and crista maintenance requires the dynamin-related GTPase Mgm1. Cell. 2006;127:383–395. - PubMed
Publication types
MeSH terms
Substances
LinkOut - more resources
Full Text Sources
Other Literature Sources
Medical
Research Materials
